
Pharmacally
REGENERA
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in REGENERA
Health TidingsREGENERA Shows Durable Benefits One Year After LumpectomyTensive reported positive 12-month interim results from its pivotal REGENERA trial in women undergoing lumpectomy. The bioresorbable implant maintained good-to-excellent cosmetic outcomes, demonstrated a favorable safety profile, improved…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.